Theravance Biopharma (NASDAQ:TBPH) and partner Mylan reached a settlement agreement with Eugia Pharma over a patent dispute ...

Theravance Biopharma and Mylan settle a patent dispute with Eugia Pharma over Yupelri, delaying generic entry until 2039.

Get latest Accretion Pharmaceuticals Ltd. Dividend history details. View Accretion Pharmaceuticals Ltd. Dividend announcement date, Ex-dividend date and final dividend.

The Nifty Pharma index jumped 1% to 21,585.35. The index increased 1.08% for the two consecutive trading sessions.

ITI Pharma and Healthcare Fund - Direct Plan - Rediff Money - India's leading finance site for latest share prices, mutual funds, nifty futures and options, graphs, expert stock Calls and share market ...

The Nifty Pharma index closed on a negative note on Monday. Shares of Glenmark Pharmaceuticals Ltd.(up 2.78 per cent), Ajanta ...

The size of India’s insulin market was an estimated Rs 4,404 crore in April this year, with Indian players making steady ...

The company’s strategy for global markets is different from the India market and is not solely based on leveraging ...

IST, the barometer index, the S&P BSE Sensex, slipped 150.18 points or 0.18% to 81,398.36. The Nifty 50 index shed 52.85 points or 0.21% to 24,776.35.

The pharmaceutical company is evaluating all options to increase its presence in therapy areas, including in-licensing ...

Novartis introduces a financing scheme with Pine Labs for its cholesterol-lowering drug, Sybrava (inclisiran), in India, ...

A handful of industries are on the verge of explosive growth. These three companies are poised to gain the most.